---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-000038"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2022-01-04T23:59:59+00:00"
generated_at: "2026-06-27T20:51:29.058768+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# RxSight appoints Shweta Maniar and Dr. Tamara Fountain to board; expands to nine members

## Summary
- Board expanded from 7 to 9; Maniar (Google Cloud) and Dr. Fountain (ophthalmologist) effective Dec 31, 2021 and Jan 1, 2022.
- Maniar serves on Governance/Nominating Committee; receives $45k annual retainer, $5k committee fee, initial RSUs valued at $217,500.
- Dr. Fountain, 2021 President of American Academy of Ophthalmology, serves on Audit Committee; receives no compensation during 2022 per AAO policy.
- Outside Director Compensation Policy updated: annual cash retainer raised from $40k to $45k; initial RSU award increased from $125k to $217,500.

## SEC filing metadata
- accession: 0000950170-22-000038
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2022-01-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017022000038/0000950170-22-000038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017022000038/rxst-20211229.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-000038
- JSON: https://secwatch.observer/filing/0000950170-22-000038.json
- Plain text: https://secwatch.observer/filing/0000950170-22-000038.txt

## Key facts
- Executive change
  Tamara Fountain, M.D. was appointed as Director at RxSight, Inc..
  - Action: appointed
  - Role: Director
  source text: On December 29, 2021 the board of directors (the “Board”) of RxSight, Inc. (the “Company”) increased the number of its authorized directors from seven to nine, and appointed Shweta Singh Maniar and Tamara Fountain, M.D. to fill the two newly created openings on the Board, effective December 31, 2021 and January 1, 2022, respectively.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000095017022000038/0000950170-22-000038-index.htm
- Executive change
  Shweta Singh Maniar was appointed as Director at RxSight, Inc..
  - Action: appointed
  - Role: Director
  source text: On December 29, 2021 the board of directors (the “Board”) of RxSight, Inc. (the “Company”) increased the number of its authorized directors from seven to nine, and appointed Shweta Singh Maniar and Tamara Fountain, M.D. to fill the two newly created openings on the Board, effective December 31, 2021 and January 1, 2022, respectively.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000095017022000038/0000950170-22-000038-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.